Organisation: Prialt

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

business

Elan and banks lead market gains

THE ISEQ Index closed in positive territory for the first day in four with Elan and the banks the main catalysts for the rise.

business

Elan to cut spending by $100m

business

Only way is down for Elan

business

Sea snails to give Elan boost in race to find painkiller

business

Positive results from Elan and Biogen

business

Elan looks to future despite results

Elan shares jump on reduction of losses

SHARES in Elan gained as much as 7% yesterday as the drug firm posted a sharp reduction in first quarter losses.

Fri, 14 May, 2004

Elan up on expected 2005 product launch

The ISEQ index of Irish shares closed down 29.77 points to 5375.06 today.

Wed, 14 Apr, 2004

Elan in $55m migraine drug deal

ELAN CORPORATION is selling the North American marketing rights for its Frova migraine product back to British biotech group Vernalis Plc for some $55 million.

Wed, 31 Mar, 2004

Market ends higher in mixed day

Shares in Dublin were mixed yesterday. The ISEQ ended the day higher at 5016.45, up 6.21 points.

Thu, 08 Jan, 2004